Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era
about
Regional and hospital variations in the extent of decline in the proportion of percutaneous coronary interventions performed for nonacute indications - a nationwide population-based study.Cardiac tissue oxidative stress and inflammation after vitamin D administrations in high fat- diet induced obese ratsSecondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion.PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights.Nutrition in primary and secondary prevention of cardiovascular risk in the continental and Mediterranean regions of Croatia.Independent association of resting energy expenditure with blood pressure: confirmation in populations of the African diaspora.Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study.Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure?Metformin restores electrophysiology of small conductance calcium-activated potassium channels in the atrium of GK diabetic rats.Is single-child family associated with cardio-metabolic risk factors: the CASPIAN-V study.The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based F-FDG PET/CT studyEvaluation of health status and its predictor among university staff in NigeriaRisk factors for prehypertension and their interactive effect: a cross- sectional survey in China
P2860
Q33784899-84F08DD8-072E-479F-8ECF-B5C9817CB35CQ33815035-2A66DA26-4315-47A5-AF9A-7E0A0ED274FBQ36273208-586DB325-BC9A-4D1D-B2D6-F3F30E017697Q41520146-9B60B33B-055D-4995-9C45-DBD2A460EDEAQ41711670-7DB006D4-69CF-445E-9170-B3EE58A387D9Q47561807-A5288C4E-2FC0-4E23-919B-E60437AD3F90Q50058090-D5CCD9BA-7600-4064-97B0-7E08E32DE813Q54266346-93C99873-00AC-4174-965D-63A3E97449A9Q55348602-FF33BBDE-EFC2-4DFC-8A7A-D66C4748D95AQ55491610-D48247A9-565B-4DF1-AC10-708D8DE2F753Q58101156-04F799A0-810B-464E-830E-1C30D641FE6FQ58711962-35B52849-796B-4DC3-B5C6-032BE87A053AQ58737508-5A462D79-D59E-4460-873D-78E03E544B13
P2860
Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Assessing Risk in Patients wit ...... es of the COURAGE and FAME Era
@ast
Assessing Risk in Patients wit ...... es of the COURAGE and FAME Era
@en
Assessing Risk in Patients wit ...... es of the COURAGE and FAME Era
@nl
type
label
Assessing Risk in Patients wit ...... es of the COURAGE and FAME Era
@ast
Assessing Risk in Patients wit ...... es of the COURAGE and FAME Era
@en
Assessing Risk in Patients wit ...... es of the COURAGE and FAME Era
@nl
prefLabel
Assessing Risk in Patients wit ...... es of the COURAGE and FAME Era
@ast
Assessing Risk in Patients wit ...... es of the COURAGE and FAME Era
@en
Assessing Risk in Patients wit ...... es of the COURAGE and FAME Era
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Assessing Risk in Patients wit ...... es of the COURAGE and FAME Era
@en
P2093
Claudio Moretti
Davide Capodanno
Fabrizio D'Ascenzo
Fiorenzo Gaita
Freek Nijhoff
Marco Lococo
Michael J Lipinski
P2860
P304
P3181
P356
10.1155/2016/3769152
P407
P577
2016-01-01T00:00:00Z